Clinical Drug Experience Knowledgebase

Carcinoma, Squamous Cell

Colorectal Neoplasms

Head and Neck Neoplasms

Adenocarcinoma (Phase 3)

Adenocarcinoma of Lung (Phase 2)

Aged (Phase 3)

Antibody-Dependent Cell Cytotoxicity (Phase 2)

Antineoplastic Agents (Phase 3)

Anus Neoplasms (Phase 2)

Appendiceal Neoplasms (Phase 1/Phase 2)

Appendix (Phase 1)

Astrocytoma (Phase 2)

Bile Duct Neoplasms (Phase 2)

Biliary Tract Neoplasms (Phase 2)

Brain Neoplasms (Phase 2)

Breast Neoplasms (Phase 2)

Capecitabine (Phase 2)

Carcinoma (Phase 2)

Carcinoma, Adenoid Cystic (Phase 1/Phase 2)

Carcinoma, Basal Cell (Phase 1/Phase 2)

Carcinoma, Hepatocellular (Phase 2)

Carcinoma, Mucoepidermoid (Phase 1/Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 3)

Carcinoma, Renal Cell (Phase 1/Phase 2)

Carcinoma, Squamous Cell (Phase 3)

Carcinoma, Transitional Cell (Phase 1/Phase 2)

Carcinoma, Verrucous (Phase 2)

Castleman Disease (Phase 1)

Cetuximab (Phase 3)

Cholangiocarcinoma (Phase 2)

Chordoma (Phase 2)

Colonic Neoplasms (Phase 4)

Colorectal Neoplasms ()

Complex Regional Pain Syndromes (Phase 2)

Diffuse Intrinsic Pontine Glioma (Phase 1/Phase 2)

Digestive System Neoplasms (Phase 1)

Disease Progression (Phase 2)

Drug-Related Side Effects and Adverse Reactions (Phase 3)

Drugs, Investigational (Phase 2)

Endometrial Neoplasms (Phase 2)

Epidermal Growth Factor (Phase 2)

ErbB Receptors (Phase 2)

Erdheim-Chester Disease (Phase 1)

Esophageal Neoplasms (Phase 3)

Esophageal Squamous Cell Carcinoma (Phase 2)

Fallopian Tube Neoplasms (Phase 2)

Gallbladder Neoplasms (Phase 2)

Gastrointestinal Stromal Tumors (Phase 1/Phase 2)

General Surgery (Phase 2)

Genes, erbB-2 (Phase 1/Phase 2)

Glioblastoma (Phase 2)

Glioma (Phase 2)

Graft vs Host Disease (Phase 2)

Granuloma (Phase 1/Phase 2)

Hamartoma (Phase 2)

Head and Neck Neoplasms (Phase 4)

Healthy Volunteers (Phase 1)

Hypopharyngeal Neoplasms (Phase 2/Phase 3)

Intestinal Neoplasms (Phase 2)

Kidney Neoplasms (Phase 1)

Laryngeal Neoplasms (Phase 2/Phase 3)

Lip (Phase 2)

Liver Diseases (Phase 2)

Liver Neoplasms (Phase 4)

Lung Diseases (Phase 1)

Lung Neoplasms (Phase 3)

Lymphangioleiomyomatosis (Phase 1)

Lymphoma (Phase 1)

Lymphoma, Non-Hodgkin (Phase 2)

Margins of Excision (Phase 1/Phase 2)

Melanoma (Phase 1)

Mouth Neoplasms (Phase 2/Phase 3)

Multiple Myeloma (Phase 2)

Mutation (Phase 3)

Nasopharyngeal Carcinoma (Phase 3)

Nasopharyngeal Neoplasms (Phase 2)

Neoadjuvant Therapy (Phase 2)

Neoplasm Metastasis (Phase 4)

Neoplasms ()

Neoplasms, Mesothelial (Phase 1)

Neoplasms, Second Primary (Phase 2)

Neoplasms, Squamous Cell (Phase 2)

Neoplasms, Unknown Primary (Phase 2)

Neoplastic Cells, Circulating (Phase 2)

Neuralgia (Phase 2)

Neuroblastoma (Phase 1/Phase 2)

Neurofibromatosis 2 (Phase 1)

Nose Neoplasms (Phase 2)

Oligodendroglioma (Phase 1/Phase 2)

Oropharyngeal Neoplasms (Phase 2/Phase 3)

Ovarian Neoplasms (Phase 2)

Pancreatic Neoplasms (Phase 3)

Papilloma, Inverted (Phase 1/Phase 2)

Papillomaviridae (Phase 2)

Paranasal Sinus Neoplasms (Phase 2)

Penile Neoplasms (Phase 1)

Peritoneal Neoplasms (Phase 2)

Pharmacological and Toxicological Phenomena (Phase 1)

Pharyngeal Neoplasms (Phase 2)

Pleural Effusion, Malignant (Phase 2)

Precancerous Conditions (Phase 3)

Prostatic Neoplasms (Phase 2)

Prostatic Neoplasms, Castration-Resistant (Phase 1)

Proto-Oncogene Proteins B-raf (Phase 2)

Quality of Life (Phase 3)

ras Proteins (Phase 2)

Rectal Neoplasms (Phase 2)

Salivary Gland Neoplasms (Phase 2)

Sarcoma (Phase 2)

Skin Diseases (Phase 2)

Skin Neoplasms (Phase 2)

Soft Tissue Neoplasms (Phase 1)

Squamous Cell Carcinoma of Head and Neck (Phase 3)

Stomach Neoplasms (Phase 3)

Thoracic Surgery, Video-Assisted (Phase 2)

Thymoma (Phase 2)

Thyroid Neoplasms (Phase 1)

Tongue Neoplasms (Phase 2)

Triple Negative Breast Neoplasms (Phase 1/Phase 2)

Urinary Bladder Neoplasms (Phase 2)

Urologic Neoplasms (Phase 2)

Uterine Cervical Neoplasms (Phase 2)